HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach

Objectives. HER2 expression in gastric cancer (GC) has received attention as a potential target for therapy with Trastuzumab. We reviewed the current knowledge on HER2 status in premalignant gastric lesions and in early (EGC) and advanced (AGC) GC to discuss the possible pathogenetic and prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ieni, A., Barresi, V., Rigoli, L., Caruso, R. A., Tuccari, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606090/
https://www.ncbi.nlm.nih.gov/pubmed/26494937
http://dx.doi.org/10.1155/2015/234851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606090/
https://www.ncbi.nlm.nih.gov/pubmed/26494937
http://dx.doi.org/10.1155/2015/234851

Ejemplares similares